Introduction {#s1}
============

After a first-ever-in-a-lifetime stroke (FELS) or transient ischemic attack (TIA), the use of hospital emergency services or hospital readmissions is common and associated with increased stroke mortality and morbidity, thus, raising the overall health burden of stroke ([@B1]). Also, despite some well-characterized limitations ([@B2]), readmissions are currently a measure of the hospital\'s performance and quality of care ([@B3]).

Several risk factors for stroke readmissions have been described. However, many meaningful clinical associations may have been ignored since most studies only rely on large administrative or single-hospital databases, particular subtypes of stroke, or readmissions in the first 3 months after stroke ([@B1], [@B4], [@B5]). This assertion is especially true in Portugal, where, to our knowledge, there are no population-based stroke readmission studies, and therefore, the corresponding information is scarce.

We aimed to study unplanned readmissions or death during the first year after a FELS and to identify their potential factors, based on a Portuguese community register.

Materials and Methods {#s2}
=====================

The sample was obtained from the second population-based register undertaken in Northern Portugal (ACIN2), comprising all FELS recorded between October 2009 and September 2011 in the population registered in the Health Centers Group of Western Porto main city (190,000 persons) and two health centers in rural regions in Northern Portugal (Mirandela and Vila Pouca de Aguiar, involving about 46,000 persons) ([@B6]). Multiple sources of information were used to identify all patients with a FELS using a record-linkage methodology based on the National Health Number, a unique identifier for residents in Portugal to contact the National Health Service (NHS). Hot-pursuit and cold-pursuit ascertainment involving community-based and hospital-based information sources were used ([@B6]). Hot-pursuit encompassed a daily review of emergency admissions and referrals to the project out-patient clinic at Hospital de Santo António. Cold pursuit was used to check for completeness of hot-pursuit identification ([@B7]). Patients were examined as soon as possible after symptoms\' onset at the emergency room, during their hospital stay or at the project out-patient clinic, within 1 month and then were followed-up until 3 months after a stroke. More detailed information is described elsewhere ([@B6]). This study includes all patients from Porto admitted to the hospital after a FELS. The information about readmissions after the 3-months follow-up period was collected retrospectively. The ethics committee of the Centro Hospitalar Universitário de São João and the Centro Hospitalar Universitário do Porto approved this study.

The World Health Organization\'s "stroke" definition and Sudlow\'s and Warlow\'s stroke pathological types---ischemic stroke (IS), intracerebral hemorrhage (ICH), and subarachnoid hemorrhage (SAH)---were considered for the corresponding concepts ([@B8], [@B9]). Brain image (computerized tomography scan/magnetic resonance imaging) was used to confirm stroke types. The TOAST criteria were used to define IS etiology and the Bamford Oxfordshire classification to define clinical IS syndromes ([@B10], [@B11]).

Stroke severity at the first medical evaluation was characterized as mild, moderate, or severe based on the National Institutes of Health Stroke Scale (NIHSS) ([@B12]) (NIHSS ≤7, 8--16, or ≥17, respectively), except for SAH. Whenever the NIHSS was unavailable, the score was estimated retrospectively from the patients\' clinical records, if valid for that purpose ([@B13]). The pre and post-stroke (\~28 days after stroke) functional outcome was assessed with the modified Rankin Scale (mRS) ([@B14]).

The following criteria were considered as pre-stroke risk factors: (a) history of hypertension or antihypertensive treatment; (b) previous diagnosis/treatment of diabetes mellitus with oral antidiabetic agent/insulin or fasting glycemia \>126 mg/dl, postprandial glycemia ≥200 mg/dl, and/or ≥200 mg/dl in the 2-h glucose tolerance test; (c) evidence of atrial fibrillation in electrocardiogram or documented in the patient\'s records; (d) previous diagnosis/treatment of hypercholesterolemia; (e) history of myocardial infarction; (f) current smoking habits (if patients had smoked at all in the preceding 12 months) ([@B6]). Other pre-stroke comorbidities such as congestive heart failure, dementia, HIV infection, and malignant neoplasm were included after reviewing patients\' medical records using the International Classification of Diseases 9th Revision (ICD-9) diagnosis code.

Planned readmissions were defined as readmissions to perform a scheduled procedure (e.g., carotid endarterectomy or stenting, patent *foramen ovale* closure, cardiac planned procedures, and cranioplasty) and planned hospitalizations (rehabilitation, chemo- or radiotherapy treatment, major organ transplant, or obstetrical delivery) ([@B15]).

Unplanned readmissions were defined as \>24-h hospitalizations due to unexpected causes and emergency episodes leading to death that did not fulfill any planned readmission criterion that had occurred within 1 year of the FELS index hospitalization (FELS-IH) ([@B15]). Unplanned readmissions after a planned admission were also acknowledged.

Patients who died during their FELS-IH were excluded. Two neurology study investigators (including a stroke neurologist) reviewed the patients\' medical records using the ICD-9 diagnosis code to obtain and validate the unplanned readmission causes. The main unplanned readmission diagnosis-related group code was identified for statistical data and subgroup analyses. A composite outcome event of unplanned first-ever readmission or death without readmission within 1 year after FELS was considered to capture all negative health outcomes ([@B3]).

Potentially avoidable readmissions (PAR) were defined as causes that could have been prevented or modified during the FELS-IH, and their clinical plausibility was defined using Goldfield et al.\'s criteria ([@B16]): (a) medical readmission for a continuation or recurrence of the reason for the initial admission, or for a closely related condition; (b) medical readmission for an acute decompensation of a chronic problem that was not the reason for the initial admission, but was plausibly related to care either during or immediately after the initial admission; (c) medical readmission for an acute medical complication plausibly related to care during the initial admission; (d) readmission for a surgical procedure to address a continuation or a recurrence of the problem causing the initial admission; (e) readmission for a surgical procedure to address a complication resulting from care during the initial admission. In case of disagreement, the study investigators reached a consensus for the readmission classification.

Stroke-related readmissions were defined as recurrent vascular events and complications that warranted readmission, including stroke, pneumonia, urinary tract infection, peripheral and coronary artery disease, hip fracture, and pulmonary embolism ([@B17], [@B18]).

Statistics
----------

Sociodemographic characteristics were summarized using descriptive statistics. The baseline and clinical characteristics of readmitted vs. non-readmitted patients were compared using the Chi-square or the Fisher exact test when adequate for categorical variables and the *t*-test or the Mann--Whitney *U* test for continuous variables (normality of distributions was assessed using the Shapiro--Wilk test). The overall cumulative readmission/death-free survival and PAR-free survival over 12 months was estimated using the Kaplan--Meyer method. Independent risk factors for readmission were evaluated using Cox proportional hazard models. ICH and SAH were combined as hemorrhagic stroke (HS) for the Kaplan--Meyer survival estimation ([Figure 2](#F2){ref-type="fig"}) and the description of characteristics and reasons for all-cause readmissions by sub-groups ([Table 3](#T3){ref-type="table"}). A value of *p* = 0.05 was considered as the limit to wrongly reject the null hypothesis. Data analysis was performed using SPSS Statistics v24.

Results {#s3}
=======

Study Cohort
------------

[Figure 1](#F1){ref-type="fig"} shows the study design for the cohort follow-up. From the initial cohort of 720 FELS patients in the ACIN2 database, we excluded 258 not hospitalized in the index event and 73 that died during the FELS-IH; 389 FELS patients at risk of an unplanned readmission/death were included. This cohort had a mean age of 70 years and 208 (53.5%) women; 317 (81.5%) had an IS in the index event, 58 (14.9%) an ICH, and 14 (3.6%) an SAH. All patients had a brain image performed.

![Study design for cohort follow-up. FELS, first-ever-in-a-lifetime stroke; FELS-IH, first-ever-in-a-lifetime-stroke index hospitalization; IS, ischemic stroke, ICH, intracerebral hemorrhage; SAH, subarachnoid hemorrhage.](fneur-11-00636-g0001){#F1}

[Table 1](#T1){ref-type="table"} shows the baseline characteristics of non-readmitted and readmitted/deceased patients. Readmitted/deceased patients were older (77.1 vs. 67.1, *p* \< 0.001), had higher pre-stroke dependency (mRS ≥ 2, 50.8% vs. 25.7%, *p* \< 0.001), and had more often hypertension (83.3% vs. 73.2%, *p* = 0.03), atrial fibrillation (AF; 32.5% vs. 20.1%, *p* = 0.008), and congestive heart failure (25.0% vs. 16.4%, *p* = 0.045). They also had had more total anterior circulation infarcts and less lacunar and posterior circulation infarcts (*p* = 0.008), more cardioembolic strokes and less small vessels or other determined infarcts (*p* = 0.019). Moreover, readmitted/deceased patients had a higher NIHSS score (9 vs. 4, *p* \< 0.001), more moderate or severe strokes (*p* \< 0.001), higher post-stroke dependency levels (mRS ≥ 2, 95.0% vs. 71.4%, *p* \< 0.001), higher likelihood of having had a previous hospital admission (18.3% vs. 8.9%, *p* = 0.008), and a higher median in-hospital length of stay (LoS) (11 vs. 8 days, *p* = 0.008). We found no differences between non-readmitted and readmitted/deceased patients regarding other baseline characteristics.

###### 

Patients\' characteristics at baseline (non-readmitted and readmitted/death).

                                                            **Overall (*****n*** **=** **389)**   **Non-readmitted (*****n*** **=** **269)**   **Readmitted/death (*****n*** **=** **120)**                              
  --------------------------------------------------------- ------------------------------------- -------------------------------------------- ---------------------------------------------- --------- ------ --------- ---------------------------------------------
  Women                                                     208                                   53.5                                         142                                            52.8      66     55.0      0.686
  Mean age (SD), years                                      70.2                                  (15.1)                                       67.1                                           (15.3)    77.1   (12.2)    **\<0.001**[^b^](#TN2){ref-type="table-fn"}
      \<45                                                  29                                    7.5                                          27                                             10.0      2      1.7       **\<0.001**
     45--64                                                 100                                   25.7                                         79                                             29.4      21     17.5      
     65--84                                                 195                                   50.1                                         140                                            52.0      55     45.8      
     ≥85                                                    65                                    16.7                                         23                                             8.6       42     35.0      
  Pre-stroke mRS≥2                                          130                                   33.4                                         69                                             25.7      61     50.8      **\<0.001**
  Pre-existing comorbidities                                                                                                                                                                                             
     Hypertension                                           297                                   76.3                                         197                                            73.2      100    83.3      **0.030**
     Diabetes mellitus                                      102                                   26.2                                         68                                             25.3      34     28.3      0.527
     Atrial fibrillation                                    93                                    23.9                                         54                                             20.1      39     32.5      **0.008**
     Myocardial infarction                                  39                                    10.0                                         28                                             10.4      11     9.2       0.706
     Hypercholesterolemia                                   182                                   46.8                                         134                                            49.8      48     40.0      0.073
     Smoking                                                144                                   37.0                                         108                                            40.1      36     30.0      0.056
     Congestive heart failure                               74                                    19.0                                         44                                             16.4      30     25.0      **0.045**
     Dementia                                               45                                    11.6                                         28                                             10.4      17     14.2      0.285
     Neoplasm                                               60                                    15.4                                         36                                             13.4      24     20.0      0.095
     HIV                                                    6                                     1.5                                          5                                              1.9       1      0.8       0.448
  Stroke pathological type                                                                                                                                                                                               0.802
     Ischemic stroke                                        317                                   81.5                                         221                                            82.2      96     80.0      
     Intracerebral hemorrhage                               58                                    14.9                                         38                                             14.1      20     16.7      
     Subarachnoid hemorrhage                                14                                    3.6                                          10                                             3.7       4      3.3       
  Ischemic stroke subtype                                                                                                                                                                                                **0.008**
     Total anterior circulation infarct                     79                                    24.9                                         44                                             19.9      35     36.5      
     Partial anterior circulation infarct                   102                                   32.2                                         71                                             32.1      31     32.3      
     Lacunar infarct                                        62                                    19.6                                         48                                             21.7      14     14.6      
     Posterior circulation infarct                          74                                    23.3                                         58                                             26.2      16     16.7      
  Ischemic stroke etiology                                                                                                                                                                                               **0.019**
     Large-artery atherosclerosis                           49                                    15.5                                         34                                             15.4      15     15.6      
     Cardioembolism                                         103                                   32.5                                         64                                             29.9      39     40.6      
     Small-artery occlusion                                 51                                    16.1                                         41                                             18.6      10     10.4      
     Other determined                                       14                                    4.4                                          14                                             6.3       0      0.0       
     Undetermined                                           100                                   31.5                                         68                                             30.8      32     33.3      
  Median NIHSS (IQR)[^a^](#TN1){ref-type="table-fn"}        5                                     (2--13)                                      4                                              (2--11)   9      (4--14)   **\<0.001**[^c^](#TN3){ref-type="table-fn"}
  Stroke severity (NIHSS)[^a^](#TN1){ref-type="table-fn"}                                                                                                                                                                **\<0.001**
      ≤ 7                                                   229                                   61.1                                         175                                            67.6      54     46.6      
     8--16                                                  92                                    24.5                                         49                                             18.9      43     37.1      
     ≥17                                                    54                                    14.4                                         35                                             13.5      19     16.4      
  Post-stroke mRS≥2                                         306                                   78.7                                         192                                            71.4      114    95.0      **\<0.001**
  Management                                                                                                                                                                                                             
     Delay less than 3 h                                    199                                   51.2                                         144                                            53.5      55     45.8      0.161
     Thrombolysis                                           48                                    15.1                                         33                                             14.9      15     15.6      0.874
     Stroke occurred while in hospital                      29                                    7.5                                          20                                             7.4       9      7.5       0.982
     Median hospital length of stay (IQR), days             9                                     (4--19)                                      8                                              (4--18)   11     (5--27)   **0.022**[^c^](#TN3){ref-type="table-fn"}
     Previous admissions                                    46                                    11.8                                         24                                             8.9       22     18.3      **0.008**

*SD, standard deviation; mRS, modified Rankin Scale; IQR, interquartile range*.

*National Institutes of Health Stroke Scale (NIHSS) excluding subarachnoid hemorrhages*.

*t-test*.

*Mann--Whitney U test*.

*Bold entries indicate statistical significance (p \< 0.05)*.

Readmission or Death Rates
--------------------------

[Figure 2](#F2){ref-type="fig"} shows the cumulative readmission or death rates. The all-cause readmission/death rate was 9.8, 23.2, and 31.6% at 30 days, 180 days, and 1 year, respectively. In cases of IS and HS, the rate was, respectively, 9.5 and 11.1% at 30 days, 22.2% and 27.8% at 180 days, and 31.2% and 33.5% at 1 year.

![Kaplan--Meier survival curve showing the probability of a stroke patient will remain free of readmission/death after discharge: **(A)** all stroke patients; **(B)** stroke patients stratified by pathological type.](fneur-11-00636-g0002){#F2}

Overall Unplanned Readmission Rates and Mortality Without Readmission
---------------------------------------------------------------------

Overall, 120 patients were readmitted/deceased within 1 year: 101 (84.2%) unplanned readmissions and 19 (15.8%) deaths without readmission ([Figure 1](#F1){ref-type="fig"}). Cumulative rates of readmission were similar to the readmission/death rates (data not shown). Of the 19 patients who had deceased without readmission at 1 year, 1/19 died within 30 days, 12/19 within 30--180 days, and 6/19 within 180--365 days.

Readmissions Causes and Characterization
----------------------------------------

[Tables 2](#T2){ref-type="table"}--[4](#T4){ref-type="table"} summarize the patients\' characteristics and the reasons for the hospital readmissions within the first year. The three most common reasons for readmission were infectious diseases (39.6%), cerebrovascular diseases (15.8%)---particularly IS (9.9%), and cardiovascular diseases (8.9%). The median time for readmission after FELS-IH was 59 days (interquartile range (IQR): 23--183 days). Of the unplanned readmissions, 32.7% occurred within 30 days, 41.6% within 30--180 days, and 25.7% within 180--365 days. The median in-hospital LoS of readmissions was 7 days (IQR: 3--17 days). Nineteen patients (18.8%) died during readmission: 7/19 within 30 days, 9/19 within 30--180 days, and 3/19 within 180--365 days.

###### 

Characteristics and causes of patients\' all-cause readmissions within 1 year.

                                                                                **Days from the first-ever readmission**                                                      
  ------------------------------------------------------------------- --------- ------------------------------------------ ------- ------------- ------- ------------ ------- ------------
  Median hospital stays (IQR), days                                   7         (3--17)                                    9       (3--23)       7       (3--17)      8       (3--14)
  Readmission case fatality[^a^](#TN4){ref-type="table-fn"}           19        18.8                                       7       21.2          9       20.1         3       11.5
  **Causes of unplanned readmissions**                                                                                                                                        
     Infectious diseases                                              40        39.6                                       13      39.4          19      45.2         8       30.8
       Respiratory tract                                              17        42.5                                       4       30.7          8       42.1         5       62.5
       Urinary tract                                                  12        30.0                                       6       46.2          6       31.6         0       0.0
       Sepsis                                                         7         17.5                                       2       15.4          3       15.7         2       25
       Other                                                          4         10.0                                       1       7.7           2       10.5         1       12.5
     Cerebrovascular disease (IS)                                     16 (10)   15.8 (9.9)                                 6 (5)   18.2 (15.2)   7 (4)   16.7 (9.5)   3 (1)   11.5 (3.8)
     Cardiovascular disease[^b^](#TN5){ref-type="table-fn"} (MI)      9 (3)     8.9 (3.0)                                  2 (0)   6.1 (0.0)     4 (1)   9.5 (2.4)    3 (2)   11.5 (7.7)
     Neoplasm                                                         8         7.9                                        3       9.1           1       2.4          4       15.4
     Gastrointestinal diseases (esophagitis/gastritis)                5 (3)     5.0 (3.0)                                  1 (1)   3.0 (3.0)     2 (1)   4.8 (2.4)    2 (1)   7.7 (3.8)
     Chronic respiratory diseases                                     4         4.0                                        0       0.0           2       4.8          2       7.7
     Other                                                            19        18.8                                       8       24.2          7       16.7         4       15.4
  Potentially avoidable readmission[^c^](#TN6){ref-type="table-fn"}   66        65.3                                       23      69.7          32      76.2         11      42.3
  Stroke-related readmission[^d^](#TN7){ref-type="table-fn"}          53        52.5                                       16      48.5          26      61.9         11      42.3

*IS, ischemic stroke; MI, myocardial infarction; IQR, interquartile range*.

*Readmission cases*.

*Cardiovascular disease includes myocardial infarction, arrhythmia, congestive heart failure, and valvular disease*.

*Potentially avoidable readmissions include medical readmission for a continuation or recurrence of the reason for the initial admission, or a closely related condition; medical readmission for an acute decompensation of a chronic problem that was not the reason for the initial admission, but was plausibly related to care either during or immediately after the initial admission; medical readmission for an acute medical complication plausibly related to care during the initial admission*.

*Stroke-related readmissions include recurrent vascular events and complications that warranted readmission, including stroke, pneumonia, urinary tract infection, peripheral and coronary artery disease, hip fracture, and pulmonary embolism*.

###### 

Characteristics and causes of patients\' all-cause readmissions within 1 year, by sub-groups: stroke type and age.

                                                                                   **Ischemic stroke (*****n*** **=** **82)**   **Hemorrhagic stroke (*****n*** **=** **19)**[^****a****^](#TN8){ref-type="table-fn"}                                                     
  -------------------------------------------------------------------------------- -------------------------------------------- --------------------------------------------------------------------------------------- ------- ----------- ------- ------------- ------- ------------
  Unplanned readmissions---all causes                                              14                                           17.1                                                                                    68      82.9        5       26.3          14      73.7
  Infectious diseases                                                              \-                                           \-                                                                                      31      45.6        2       40.0          7       50.0
     Respiratory tract                                                             \-                                           \-                                                                                      16      51.6        \-      \-            1       14.3
     Urinary tract                                                                 \-                                           \-                                                                                      9       29          1       50.0          2       28.6
     Sepsis                                                                        \-                                           \-                                                                                      3       9.7         \-      \-            4       57.1
     Other                                                                         \-                                           \-                                                                                      3       9.7         1       50.0          \-      \-
  Cerebrovascular disease (ischemic stroke)                                        4 (3)                                        4.9 (3.7)                                                                               8 (6)   11.7(8.8)   \-      \-            4 (1)   28.6 (7.1)
  Cardiovascular disease[^b^](#TN9){ref-type="table-fn"} (myocardial infarction)   2 (0)                                        2.4 (0.0)                                                                               5 (2)   6.1 (2.9)   1 (1)   20.0 (20.0)   1 (0)   7.1 (0.0)
  Neoplasm                                                                         2                                            14.3                                                                                    5       7.4         \-      \-            \-      \-
  Gastrointestinal diseases (esophagitis/gastritis)                                1 (1)                                        7.1 (7.1)                                                                               3 (1)   4.4 (1.5)   \-      \-            \-      \-
  Chronic respiratory diseases                                                     2                                            14.3                                                                                    1       1.5         \-      \-            1       7.1
  Other                                                                            3                                            2.1                                                                                     15      22.1        2       40.0          1       7.1
  Potentially avoidable readmissions[^c^](#TN10){ref-type="table-fn"}              7                                            50.0                                                                                    43      63.2        2       40.0          14      100.0
  Stroke-related readmissions[^d^](#TN11){ref-type="table-fn"}                     4                                            28.6                                                                                    40      58.8        2       40.0          7       50.0
  Readmission case-fatality                                                        1                                            7.1                                                                                     16      23.5        \-      \-            2       14.3

*Includes intracerebral and subarachnoid hemorrhage*.

*Cardiovascular disease includes myocardial infarction, arrhythmia, congestive heart failure and valvular disease*.

*Potentially avoidable readmissions include medical readmission for a continuation or recurrence of the reason for the initial admission or a closely related condition; medical readmission for an acute decompensation of a chronic problem that was not the reason for the initial admission but was plausibly related to care either during or immediately after the initial admission; medical readmission for an acute medical complication plausibly related to care during the initial admission*.

*Stroke-related readmissions include recurrent vascular events and complications that warranted readmission, including stroke, pneumonia, urinary tract infection, peripheral and coronary artery disease, hip fracture, and pulmonary embolism*.

###### 

Baseline characteristics of patients\' readmitted within 1 year, by sub-groups: avoidable and non-avoidable.

                                                             **Overall (*****n*** **=** **101)**   **Non-avoidable (*****n*** **=** **35)**   **Avoidable (*****n*** **=** **66)**                              
  ---------------------------------------------------------- ------------------------------------- ------------------------------------------ -------------------------------------- --------- ------ --------- --------------------------------------------
  Women                                                      55                                    54.5                                       17                                     48.6      38     57.6      0.387
  Mean age (SD), years                                       76.9                                  (11.9)                                     73.3                                   (13.3)    78.7   (10.7)    **0.035**[^b^](#TN13){ref-type="table-fn"}
      \<45                                                   2                                     7.5                                        2                                      5.7       0      0.0       
     45--64                                                  17                                    25.7                                       8                                      22.9      9      13.6      
     65--84                                                  49                                    50.1                                       18                                     51.4      31     47        
     ≥85                                                     33                                    16.7                                       7                                      20.0      26     39.4      
  Pre-stroke mRS ≥ 2                                         51                                    50.5                                       16                                     45.7      35     53        0.484
  Pre-existing comorbidities                                                                                                                                                                                    
     Hypertension                                            84                                    83.2                                       29                                     82.9      55     83.3      0.951
     Diabetes mellitus                                       27                                    26.7                                       11                                     31.4      16     24.2      0.437
     Atrial fibrillation                                     32                                    31.7                                       9                                      25.7      23     34.8      0.348
     Myocardial infarction                                   9                                     8.9                                        1                                      2.9       8      12.1      0.120
     Hypercholesterolemia                                    43                                    42.6                                       16                                     45.7      27     40.9      0.642
     Smoking                                                 32                                    31.7                                       12                                     34.3      20     30.3      0.682
     Congestive heart failure                                25                                    24.8                                       6                                      17.1      19     28.8      0.197
     Dementia                                                12                                    11.9                                       2                                      5.7       10     15.2      0.290
     Neoplasm                                                19                                    18.8                                       11                                     31.4      8      12.1      **0.018**
     HIV                                                     1                                     1.0                                        1                                      2.9       0      0.0       0.347
  Stroke pathological type                                                                                                                                                                                      0.216
     Ischemic stroke                                         82                                    81.2                                       32                                     91.4      50     75.8      
     Intracerebral hemorrhage                                15                                    14.9                                       3                                      8.6       12     18.2      
     Subarachnoid hemorrhage                                 4                                     3.9                                        0                                      0.0       4      6.1       
  Ischemic stroke subtype                                                                                                                                                                                       0.129
     Total anterior circulation infarct                      30                                    36.6                                       7                                      21.9      23     46.0      
     Partial anterior circulation infarct                    24                                    29.3                                       10                                     31.3      14     28.0      
     Lacunar infarct                                         13                                    15.9                                       7                                      21.9      6      12.0      
     Posterior circulation infarct                           15                                    18.3                                       8                                      25.0      7      14.0      
  Ischemic stroke etiology                                                                                                                                                                                      0.702
     Large-artery atherosclerosis                            12                                    14.6                                       7                                      21,9      5      10.0      
     Cardioembolism                                          36                                    43.9                                       11                                     34.4      25     50.0      
     Small-artery occlusion                                  10                                    12.2                                       5                                      15.6      5      10.0      
     Other determined                                        5                                     6.1                                        3                                      9.4       2      4.0       
     Undetermined                                            19                                    23.2                                       8                                      25.0      11     22.0      
  Median NIHSS (IQR)[^a^](#TN12){ref-type="table-fn"}        8                                     (4--14)                                    6                                      (3--9)    10     (5--15)   **0.008**[^c^](#TN14){ref-type="table-fn"}
  Stroke severity (NIHSS)[^a^](#TN12){ref-type="table-fn"}                                                                                                                                                      **0.005**
      ≤ 7                                                    48                                    49.5                                       25                                     71.4      23     37.1      
     8--16                                                   35                                    36.1                                       7                                      20.0      28     45.2      
     ≥17                                                     14                                    14.4                                       3                                      8.6       11     17.7      
  Post-stroke mRS ≥ 2                                        95                                    94.1                                       33                                     94.3      62     93.9      0.657
  Management                                                                                                                                                                                                    
     Delay less than 3 h                                     46                                    45.5                                       15                                     42.9      31     47.0      0.693
     Thrombolysis                                            14                                    13.9                                       4                                      11.4      10     15.2      0.606
     Stroke occurred while in hospital                       7                                     6.9                                        3                                      8.6       4      6.1       0.636
     Median hospital length of stay (IQR), days              10                                    (5--22)                                    8                                      (3--18)   12.5   (7--26)   **0.030**[^c^](#TN14){ref-type="table-fn"}
  Previous admissions                                        18                                    17.8                                       9                                      25.7      9      13.6      0.257

*SD, standard deviation; mRS, modified Rankin Scale; IQR, interquartile range*.

*National Institutes of Health Stroke Scale (NIHSS) excluding subarachnoid hemorrhages*.

*t-test*.

*Mann--Whitney U test*.

*Bold entries indicate statistical significance (p \< 0.05)*.

Potentially Avoidable Readmissions
----------------------------------

PAR occurred in 66 (65.3%) of the readmitted patients: 47 (71.2%) due to medical readmission for a continuation or recurrence of the reason for the initial admission, or for a closely related condition; 6 (9.1%) due to medical readmission for an acute decompensation of a chronic problem that was not the reason for the initial admission but was plausibly related to care either during or immediately after the initial admission; and 13 (19.7%) due to a medical readmission for an acute medical complication plausibly related to care during the initial admission; and no readmissions for a surgical procedure were observed. The PAR rate was 6.0, 15.1, and 18.5% at 30 days, 180 days, and 1 year, respectively ([Figure 3](#F3){ref-type="fig"}). Compared to non-avoidable readmissions ([Table 4](#T4){ref-type="table"}), PAR patients were older (78.7 vs. 73.3 years old, *p* = 0.035), had less neoplasms (31.4% vs. 12.1%, *p* = 0.018), a higher NIHSS score (10 vs. 6, *p* = 0.008), more moderate or severe strokes (*p* = 0.008), and a higher median in-hospital LoS (13 vs. 8 days, *p* = 0.030).

![Kaplan--Meier survival curve showing the probability of a stroke patient remaining free of non-avoidable readmissions after discharge.](fneur-11-00636-g0003){#F3}

Stroke-Related Readmissions
---------------------------

Stroke-related readmissions represented 52.5% of readmissions and occurred in 48.5, 61.9, and 42.3% of the patients readmitted within 30 days, 30--180 days, and 180--365 days, respectively ([Table 2](#T2){ref-type="table"}).

Factors Associated With Readmission or Death
--------------------------------------------

[Table 5](#T5){ref-type="table"} shows the univariate and multivariate analyses for all-cause readmission or death within 1 year. Age, previous functional status, hypertension, AF, congestive heart failure, initial NIHSS score, post-stroke functional status, disabling stroke, FELS-IH LoS, and previous admissions were significantly associated with readmission or death within 1 year, in the univariate model analysis. Conversely, being a current smoker was negatively associated with this outcome. In the multivariate regression analysis, only the male gender, age, previous and post-stroke functional status, and FELS-IH LoS remained independent factors of readmission/death within 1 year.

###### 

Univariate and multivariate readmission analyses.

                                            **Univariate**                **Multivariate**                       
  ----------------------------------------- ---------------- ------------ ------------------ ------ ------------ -------------
  Men vs. women                             0.88             0.61--1.26   0.478              2.09   1.21--3.60   **0.008**
  Age, years                                1.05             1.04--1.07   **\<0.001**        1.04   1.02--1.07   **\<0.001**
  Pre-stroke mRS ≥ 2 vs. mRS \<2            2.59             1.81--3.70   **\<0.001**        1.77   1.20--2.63   **0.004**
  Pre-existing comorbidities (yes vs. no)                                                                        
   Hypertension                             1.73             1.07--2.80   **0.025**          1.25   0.74--2.11   0.398
   Diabetes mellitus                        1.14             0.77--1.70   0.506              1.03   0.67--1.59   0.906
   Atrial fibrillation                      1.76             1.20--2.58   **0.004**          1.06   0.69--1.62   0.807
   Myocardial infarction                    0.88             0.47--1.64   0.689              0.61   0.31--1.19   0.146
   Hypercholesterolemia                     0.73             0.51--1.06   0.094              0.81   0.55--1.19   0.809
   Smoking                                  0.64             0.43--0.94   **0.023**          0.58   0.33--1.00   0.051
   Congestive heart failure                 1.60             1.06--2.41   **0.027**          1.00   0.64--1.57   0.992
   Dementia                                 1.41             0.85--2.36   0.186              0.80   0.46--1.37   0.412
   Neoplasm                                 1.43             0.92--2.24   0.114              1.36   0.85--2.18   0.196
   HIV                                      0.45             0.06--3.21   0.425              0.94   0.12--7.18   0.948
  Ischemic stroke vs. others                0.88             0.57--1.38   0.589              0.81   0.51--1.29   0.372
  NIHSS[^\*^](#TN15){ref-type="table-fn"}   1.04             1.01--1.06   **0.002**                              
  Post-stroke mRS ≥ 2                       6.38             2.81--14.5   **\<0.001**        3.17   1.34--7.49   **0.009**
  Hospital stay, days                       1.01             1.00--1.01   **0.003**          1.01   1.00--1.01   **0.046**
  Previous admissions                       1.96             1.23--3.11   **0.004**          1.32   0.80--2.19   0.273

*mRS, modified Rankin Scale; NIHSS, National Institutes of Health Stroke Scale*.

*NIHSS was calculated only for ischemic and hemorrhagic strokes*.

*Bold entries indicate statistical significance (p \< 0.05)*.

Discussion {#s4}
==========

Our study showed that 31.6% of FELS-IH survivors were readmitted/dead within 1 year. Infections, stroke recurrence, and cardiovascular diseases were the most common causes. More than half of the readmissions were PAR or stroke-related. Only the male gender, age, previous and post-stroke functional status, and FELS-IH LoS were independent factors of readmission/death.

In literature, the 1-year stroke readmission/death rate varies between 13 and 62% ([@B4], [@B5], [@B19]). Such a wide variation reflects different study methodologies and national health realities. Our results are within this range. Likewise, our readmission/death rate by stroke type confirms the lower-end range of previously reported readmission/death rates regarding IS (31 to 49%) ([@B20], [@B21]) and ICH (33 to 44.7%) ([@B22]--[@B24]), particularly in two Portuguese single-data center studies (IS, 34%; ICH, 33%) ([@B22], [@B25]).

The main differences between non-readmitted and readmitted/deceased patients (e.g., age, stroke comorbidities, stroke type/etiology, pre- and post-stroke disability, LoS, and previous admissions) fit the pattern of other readmission studies\' cohorts, such as those identified by Koennecke et al., of in-hospital worse stroke outcome/morbidity ([@B26]). Hence, these factors may help recognize individuals who are more vulnerable to readmission and must be considered in the clinical setting ([@B1], [@B4], [@B26], [@B27]). One-third of readmissions/deaths in our cohort occurred within 30 days after discharge. Nevertheless, the readmission/death risk endured after this period, as reported in other studies ([@B18]). Also, readmission case fatality at 30 days was higher than that reported for the general all-hospital in a Portuguese readmission administrative database study (21 vs. 9.5%) ([@B28]). As in the French Dijon Stroke registry cohort, this finding shows that readmission negatively affected survival ([@B29]).

In our study, the main causes of readmission were infections, stroke recurrence, and cardiovascular diseases, as in other cohorts ([@B1]). While infectious diseases dominated the 1-year readmission causes, over the year, readmissions due to cerebrovascular diseases decreased, and those due to cardiovascular diseases increased; this suggests an increasing importance of cardiac disease overtime after stroke ([@B21], [@B30]).

More than half of our readmissions were PAR, and these were highest within 180 days after FELS-IH. The few reports addressing this issue in stroke cohorts study PAR only within a 30-days period, and comparatively, PAR at 30 days were higher in our study ([@B31]--[@B34]). Nonetheless, this difference may reflect a different methodology for PAR report more than a contrasting stroke treatment reality ([@B34]). Moreover, we identified differences in the characteristics of PAR patients compared to non-avoidable readmission patients that may explain their proneness to this type of readmission; e.g., they were older, had higher NIHSS scores, more severe strokes, and higher median in-hospital LoS.

Theoretically, most of our readmissions were preventable since their causes rely on the transitional and outpatient quality of care after the initial hospitalization, including secondary prevention measures ([@B24]). On the other hand, as explained by Bjerkreim et al. ([@B20]), severe stroke patients, even when appropriately treated, are prone to infections due to repeated pulmonary aspiration and urinary catheterizations, and because strokes may affect the immunological status ([@B20], [@B35]). Furthermore, the natural disease history and the stroke early phase prothrombotic state may explain some readmissions due to vascular events, despite proper secondary prevention measures ([@B20], [@B27]).

Most stroke-related readmissions also occurred shortly after FELS-IH and persisted over the year. This finding is coherent with the aforementioned temporal pattern of readmission causes and highlights the need for more targeted specific interventions ([@B34]).

Hypertension, AF, and congestive heart failure are well-recognized stroke risk factors ([@B27], [@B29]) and were identified in our cohort univariate analysis as independent readmission/death risk factors. Thus, in order to prevent subsequent readmissions/deaths, besides the constant monitoring of stroke secondary prevention treatments, patients must also be aware of stroke warning signs and educated about the importance of controlling stroke risk factors and adhering to the recommended medication and behavioral changes in the long term ([@B29], [@B36]--[@B39]). This last goal may be achieved in the aftercare of stroke with well-designed and targeted multifactorial intervention programs of support, as described in the INSPiRE-TMS study ([@B38]).

Although smoking habits are considered a deleterious stroke risk factor ([@B40]), the univariate analysis showed that being a current smoker may be a protective factor of readmission/death. As explained elsewhere ([@B41]), this may be due to potential misreporting of patients\' smoking status, or a bias since the sickest individuals (most prone to readmission/death) might had already stopped smoking because of their morbidity status.

Our study\'s multivariate analysis reinforced the evidence that age, previous and post-stroke functional status, and FELS-IH LoS are important independent factors of readmission/death ([@B1], [@B5]).

Although seldom referred in the literature ([@B1], [@B4]), the male sex was also an independent predictor of readmission/death in our study; this might be due to their proneness to recurrent IS ([@B42]); nevertheless, this hypothesis is not consensual in the literature ([@B43]).

Our study has some limitations. Since information about readmissions/death was collected retrospectively 3 months after FELS, there is an inherent data collection bias, which we mitigated using information from the medical records instead of only from administrative data. Also, our definitions for the vascular risk factors may have led to a decreased report rate, e.g., patients with no information regarding their smoking habits were considered non-smokers. We might have underestimated the true proportion of readmissions by not collecting data from private hospitals, but this information was probably registered posteriorly in the patients\' NHS medical records, which we analyzed. Last, we did not include some complications in the FELS-IH or the type of discharge destination, which in other studies were linked to the readmission risk ([@B1]).

Conclusion {#s5}
==========

Almost one-third of FELS survivors were readmitted/dead 1 year after their FELS-IH. This outcome persisted after the first months after stroke hospitalization in all stroke subtypes. More than half of readmissions were considered potentially avoidable or stroke related, and the main cause of potentially avoidable readmissions was continuation/recurrence of the event responsible for the initial admission or a closely related condition. Identifying potentially modifiable causes of readmissions and stroke survivors more prone to readmissions, as we have done in this study, may help organizations allocate resources and implement targeted readmission reduction policies.
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FELS

:   first-ever-in-a-lifetime stroke

FELS-IH

:   first-ever-in-a-lifetime stroke index hospitalization

NHS

:   National Health Service

TIA

:   transient ischemic attack

IS

:   ischemic stroke

ICH

:   intracerebral hemorrhage

SAH

:   subarachnoid hemorrhage

TOAST

:   Trial of Org 10172 in Acute Stroke Treatment

NIHSS

:   National Institutes of Health Stroke Scale

mRS

:   Modified Rankin Scale

ICD-9

:   International Classification of Diseases 9th Revision

PAR

:   potentially avoidable readmissions

HS

:   hemorrhagic stroke

LoS

:   length of stay

IQR

:   interquartile range

MI

:   myocardial infarction

SD

:   standard deviation.
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